http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190018968-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ad4c9403364a2277dc906d5bc5642e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2795-00031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K10-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
filingDate 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e7ccfafce82b22b7c9bf3f18209405c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ab1c0fee1e6a4d169a047516d3717be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfbb81429999a67212a3a011d63f6a76
publicationDate 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20190018968-A
titleOfInvention Novel bacteriophage having bacteriocidal activity against pathogenic enterobacteria and uses thereof
abstract The present invention relates to a novel bacteriophage (KFS-YE) having killing activity against intestinal bacteria belonging to the genus Yersinia , genus Shigella or Escherichia coli and uses thereof. The bacteriophage of the present invention is a strain of the genus Yersinia , a strain of the genus Shigella and a strain of Escherichia The bacteriophage or culture thereof is effective for the pharmaceutical composition for preventing or treating diseases caused by the above-mentioned fungi, antibiotics, feed additives for antibacterial and the like, as it exhibits specific proliferation inhibitory or killing activity against E. coli .
priorityDate 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100116289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110041670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110041698-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24293
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566935
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811

Total number of triples: 39.